Trial intelligence / Profile preview

MP29-02 in Seasonal Allergic Rhinitis

NCT00660517Phase 3Completed

Sponsor
Meda
Start
Dec 2007
Primary completion
Feb 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Meda. Started Dec 2007; status: completed.

02

Drugs

fluticasone propionate nasal spray
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT00660517.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00660517.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call